<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/21/379j–12" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/21/379j–12/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/21/379j–12/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_379j_12"><akn:num>379j–12</akn:num><akn:heading>Authority to assess and use animal drug fees</akn:heading><akn:content><akn:p>§ 379j–12. Authority to assess and use animal drug fees(a) Types of feesBeginning in fiscal year 2004, the Secretary shall assess and collect fees in accordance with this section as follows:(1) Animal drug application and supplement fee(A) In generalEach person that submits, on or after September 1, 2003, an animal drug application or a supplemental animal drug application shall be subject to a fee as follows:(i) A fee established in subsection (c) for an animal drug application, except an animal drug application subject to the criteria set forth in section 360b(d)(4) of this title.

(ii) A fee established in subsection (c), in an amount that is equal to 50 percent of the amount of the fee under clause (i), for—(I) a supplemental animal drug application for which safety or effectiveness data are required;

(II) an animal drug application subject to the criteria set forth in section 360b(d)(4) of this title; and

(III) an application for conditional approval under section 360ccc of this title of a new animal drug for which an animal drug application submitted under section 360b(b)(1) of this title has been previously approved under section 360b(d)(1) of this title for another intended use.



(B) PaymentThe fee required by subparagraph (A) shall be due upon submission of the animal drug application or supplemental animal drug application.


(C) Exceptions for previously filed application or supplement(i) If an animal drug application or a supplemental animal drug application was submitted by a person that paid the fee for such application or supplement, was accepted for filing, and was not approved or was withdrawn (without a waiver or refund), the submission of an animal drug application or a supplemental animal drug application for the same product by the same person (or the person’s licensee, assignee, or successor) shall not be subject to a fee under subparagraph (A).

(ii) Beginning with fiscal year 2019, in the case of an animal drug application submitted by a </akn:p></akn:content><akn:subsection eId="subsec_379j_12_a"><akn:num>(a)</akn:num><akn:heading>Types of fees</akn:heading><akn:content><akn:p>(a) Types of fees Beginning in fiscal year 2004, the Secretary shall assess and collect fees in accordance with this section as follows:</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_379j_12_b"><akn:num>(b)</akn:num><akn:heading>Fee revenue amounts</akn:heading><akn:content><akn:p>(b) Fee revenue amounts</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_379j_12_c"><akn:num>(c)</akn:num><akn:heading>Annual fee setting; adjustments</akn:heading><akn:content><akn:p>(c) Annual fee setting; adjustments</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_379j_12_d"><akn:num>(d)</akn:num><akn:heading>Fee waiver or reduction; exemptions from fees</akn:heading><akn:content><akn:p>(d) Fee waiver or reduction; exemptions from fees</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_379j_12_e"><akn:num>(e)</akn:num><akn:heading>Effect of failure to pay fees</akn:heading><akn:content><akn:p>(e) Effect of failure to pay fees An animal drug application or supplemental animal drug application submitted by a person subject to fees under subsection (a) shall be considered incomplete and shall not be accepted for filing by the Secretary until all fees owed by such person have been paid. An investigational animal drug submission under section 379j–11(5)(B) of this title that is submitted by a person subject to fees under subsection (a) shall be considered incomplete and shall not be accepted for review by the Secretary until all fees owed by such person have been paid. The Secretary may discontinue review of any animal drug application, supplemental animal drug application or investigational animal drug submission from a person if such person has not submitted for payment all fees owed under this section by 30 days after the date upon which they are due.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_379j_12_f"><akn:num>(f)</akn:num><akn:heading>Assessment of fees</akn:heading><akn:content><akn:p>(f) Assessment of fees</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_379j_12_g"><akn:num>(g)</akn:num><akn:heading>Crediting and availability of fees</akn:heading><akn:content><akn:p>(g) Crediting and availability of fees</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_379j_12_h"><akn:num>(h)</akn:num><akn:heading>Collection of unpaid fees</akn:heading><akn:content><akn:p>(h) Collection of unpaid fees In any case where the Secretary does not receive payment of a fee assessed under subsection (a) within 30 days after it is due, such fee shall be treated as a claim of the United States Government subject to subchapter II of chapter 37 of title 31.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_379j_12_i"><akn:num>(i)</akn:num><akn:heading>Written requests for waivers, reductions, and refunds</akn:heading><akn:content><akn:p>(i) Written requests for waivers, reductions, and refunds To qualify for consideration for a waiver or reduction under subsection (d), or for a refund of any fee collected in accordance with subsection (a), a person shall submit to the Secretary a written request for such waiver, reduction, or refund not later than 180 days after such fee is due.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_379j_12_j"><akn:num>(j)</akn:num><akn:heading>Construction</akn:heading><akn:content><akn:p>(j) Construction This section may not be construed to require that the number of full-time equivalent positions in the Department of Health and Human Services, for officers, employees, and advisory committees not engaged in the process of the review of animal drug applications, be reduced to offset the number of officers, employees, and advisory committees so engaged.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>